Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Nutrition/Gastroenterology

Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation

  • Read more about Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation

The Effects of Ivacaftor on CF Fatty Acid Metabolism: An Analysis from the GOAL Study

  • Read more about The Effects of Ivacaftor on CF Fatty Acid Metabolism: An Analysis from the GOAL Study

A Novel Guluronate Oligomer Improves Intestinal Transit and Survival in Cystic Fibrosis Mice

  • Read more about A Novel Guluronate Oligomer Improves Intestinal Transit and Survival in Cystic Fibrosis Mice

Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis

  • Read more about Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis

International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: associated factors and outcome.

  • Read more about International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: associated factors and outcome.

Low sodium status in cystic fibrosis-as assessed by calculating fractional Na+ excretion-is associated with decreased growth parameters.

  • Read more about Low sodium status in cystic fibrosis-as assessed by calculating fractional Na+ excretion-is associated with decreased growth parameters.

Gastric emptying and gastro-oesophageal reflux in children with cystic fibrosis

  • Read more about Gastric emptying and gastro-oesophageal reflux in children with cystic fibrosis

Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients

  • Read more about Estimating body composition from skinfold thicknesses and bioelectrical impedance analysis in cystic fibrosis patients

Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment.

  • Read more about Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment.
  • first
  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)